Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1188: 228-32, 2008 Jan 10.
Article in English | MEDLINE | ID: mdl-18036513

ABSTRACT

Transmeningeal pharmacotherapy has been proposed to treat neurological disorders with localized pathology, such as intractable focal epilepsy. As a step toward understanding the diffusion and intracortical spread of transmeningeally delivered drugs, the present study used histological methods to determine the extent to which a marker compound, N-methyl-D-aspartate (NMDA), can diffuse into the neocortex through the meninges. Rats were implanted with bilateral parietal cortical epidural cups filled with 50 mM NMDA on the right side and artificial cerebrospinal fluid (ACSF) in the contralateral side. After 24 h, the histological effects of these treatments were evaluated using cresyl violet (Nissl) staining. The epidural NMDA exposure caused neuronal loss that in most animals extended from the pial surface through layer V. The area indicated by this neuronal loss was localized to the neocortical region underlying the epidural cup. These results suggest that NMDA-like, water soluble, small molecules can diffuse through the subdural/subarachnoid space into the underlying neocortex and spread in a limited fashion, close to the meningeal penetration site.


Subject(s)
Meninges/drug effects , N-Methylaspartate/pharmacokinetics , Neocortex/drug effects , Neurotoxins/pharmacokinetics , Subarachnoid Space/drug effects , Subdural Space/drug effects , Animals , Cell Death/drug effects , Cell Death/physiology , Coloring Agents , Diffusion/drug effects , Epidural Space/drug effects , Epidural Space/physiology , Indicators and Reagents , Infusion Pumps, Implantable , Male , Meninges/physiology , Methylene Blue , Neocortex/physiology , Nerve Degeneration/chemically induced , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Rats , Rats, Long-Evans , Solubility/drug effects , Subarachnoid Space/physiology , Subdural Space/physiology
2.
Epilepsy Res ; 75(1): 10-7, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17478079

ABSTRACT

Transmeningeal drug delivery, using an implanted hybrid neuroprosthesis, has been proposed as a novel therapy for intractable focal epilepsy. As part of a systematic effort to identify the optimal compounds and protocols for such a therapy, this study aimed to determine whether transmeningeal gamma-aminobutyric acid (GABA) delivery can terminate and/or prevent neocortical seizures in rats. Rats were chronically implanted with an epidural cup and an adjacent EEG electrode in the right parietal cortex. While the rat was behaving freely, a seizure-inducing concentration of acetylcholine (Ach) was applied into the cup. In a seizure termination study, either artificial cerebrospinal fluid (ACSF) or GABA (0.25, 2.5, 25 or 50mM) was delivered into the exposed neocortical area during an ongoing seizure. In a seizure prevention study, either ACSF or 50mM GABA was delivered into the epidural cup before the application of Ach. Epidural delivery of 50mM GABA completely terminated ongoing Ach-induced EEG seizures and convulsions within 17-437s after its delivery. ACSF and lower concentrations of GABA did not produce this effect, but 25mM GABA reduced seizure severity. However, the used GABA concentration could not prevent the development, or affect the severity, of Ach-induced EEG seizures and convulsions. This study indicates that transmeningeal GABA delivery can be used for terminating neocortical seizures, but to achieve seizure prevention via this route either a more efficient GABA delivery method needs to be developed or other neurotransmitters/pharmaceuticals should be employed for this purpose.


Subject(s)
Anticonvulsants/administration & dosage , Neocortex/drug effects , Seizures/drug therapy , gamma-Aminobutyric Acid/administration & dosage , Acetylcholine , Analysis of Variance , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Routes , Drug Interactions , Electroencephalography , Fourier Analysis , Glial Fibrillary Acidic Protein/metabolism , Male , Rats , Rats, Long-Evans , Seizures/chemically induced , Seizures/pathology , Seizures/physiopathology
3.
J Neuropathol Exp Neurol ; 65(1): 45-54, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16410748

ABSTRACT

Ultrastructural studies of neurofibrillary tangles in Alzheimer disease (AD) have demonstrated a close relationship between nuclear pores and the cytoplasmic paired helical filaments comprising the tangles, as well as nuclear irregularity in many tangle-bearing neurons; nuclear pore aggregation has been observed in nearby neurons. These observations prompted examination of the nuclear pore complex (NPC) and proteins critical to nucleocytoplasmic transport in neurons with and without tangles in AD and control cases. Light microscopic study of hippocampus and neocortex in AD and controls revealed that all nuclei were labeled by antibodies to NPC proteins, including the central transporter nucleoporin Nup62. Nucleoporin and tau label revealed significantly more nuclear irregularity in AD, often associated with neurofibrillary tangles. Double label of Nup62 with apoptotic markers (TUNEL and active caspase-3) and a cell-cycle protein (cyclin B1) revealed no clear relationship of nuclear irregularity to apoptosis or cell-cycle protein expression. However, cytoplasmic accumulation of nuclear transport factor 2 (NTF2), a protein that transports cargo from the cytoplasm into the nucleus, was observed in a subset of hippocampal neurons with and without tangles in AD but not control cases. Further investigation of the NPC and nucleocytoplasmic transport in AD is warranted.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Neurons/pathology , Nuclear Pore Complex Proteins/metabolism , Nuclear Pore/metabolism , Alzheimer Disease/physiopathology , Biopsy/methods , Caspase 3 , Caspases/metabolism , Cell Count/methods , Frontal Lobe/metabolism , Frontal Lobe/pathology , Humans , Immunohistochemistry/methods , In Situ Nick-End Labeling/methods , Microscopy, Electron, Transmission/methods , Models, Neurological , Neurofibrillary Tangles/metabolism , Neurofibrillary Tangles/pathology , Neurofibrillary Tangles/ultrastructure , Neurons/metabolism , Neurons/ultrastructure , Nuclear Pore/ultrastructure , Nucleocytoplasmic Transport Proteins/metabolism , tau Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...